Cargando…
Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters
BACKGROUND: Adjuvant therapy increases disease-free survival in endometrial cancer (EC), but has no impact on overall survival and negatively influences the quality of life. We investigated the discriminatory power of classical and immunological predictors of recurrence in a cohort of EC patients an...
Autores principales: | Versluis, M A, de Jong, R A, Plat, A, Bosse, T, Smit, V T, Mackay, H, Powell, M, Leary, A, Mileshkin, L, Kitchener, H C, Crosbie, E J, Edmondson, R J, Creutzberg, C L, Hollema, H, Daemen, T, de Bock, G H, Nijman, H W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559831/ https://www.ncbi.nlm.nih.gov/pubmed/26217922 http://dx.doi.org/10.1038/bjc.2015.268 |
Ejemplares similares
-
Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer
por: Stelloo, Ellen, et al.
Publicado: (2016) -
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
por: Gooden, M J M, et al.
Publicado: (2011) -
Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
por: Gooden, M J M, et al.
Publicado: (2014) -
Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer
por: Leffers, N, et al.
Publicado: (2010) -
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
por: León-Castillo, Alicia, et al.
Publicado: (2020)